US Stock MarketDetailed Quotes
PRQR ProQR Therapeutics
- 1.8600
- -0.0400-2.11%
Close Apr 18 16:00 ET
- 1.8995
- +0.0395+2.12%
Post 17:40 ET
151.32MMarket Cap-4973P/E (TTM)
2.0500High1.8100Low182.73KVolume1.9400Open1.9000Pre Close346.40KTurnover0.32%Turnover RatioLossP/E (Static)81.35MShares3.290052wk High3.43P/B106.93MFloat Cap1.110052wk Low--Dividend TTM57.49MShs Float27.6000Historical High--Div YieldTTM12.63%Amplitude0.5300Historical Low1.8950Avg Price1Lot Size
About ProQR Therapeutics Company
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
Company Profile
SymbolPRQR
Company NameProQR Therapeutics
Listing DateSep 18, 2014
Issue Price13.00
Founded2012
CEOMr. Daniel de Boer
MarketNASDAQ
Employees157
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressZernikedreef 9
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 CK
Phone31-88-166-70-00
Websitehttp://www.proqr-tx.com
Company Executives
- Name
- Position
- Salary
- Daniel de Boer
- Chief Executive Officer
- 2.44M
- Rene Beukema
- Chief Corporate Development Officer and General Counsel
- 1.31M
- Sheila Sponselee
- Chief People and Operations Officer
- --
- Jurriaan Dekkers
- Chief Financial Officer
- --
- Gerard Platenburg
- Chief Scientific Officer
- --
- Dinko Valerio
- Chairman of the Supervisory Board
- 150.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg